Cytek Biosciences (CTKB) Current Deferred Revenue (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Current Deferred Revenue came in at $30.0 million in Q1 2026, up 8.4% YoY from $27.7 million in Q1 2025, and up 5.36% on a QoQ basis from $28.5 million in Q4 2025.
Cytek Biosciences (CTKB) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Current Deferred Revenue data on file, last reported at $30.0 million in Q1 2026.
- Quarterly Current Deferred Revenue rose 8.4% year-over-year to $30.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.0 million (up 8.4% YoY) and the FY2025 annual result came in at $28.5 million, up 11.82% from the prior year.
- Current Deferred Revenue improved to $30.0 million in Q1 2026, from $28.5 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $30.0 million in Q1 2026 to a low of $10.0 million in Q1 2022.
- A 5-year average of $22.6 million and a median of $24.0 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue surged 105.49% — and 2024, when it slipped 19.13%.
- Tracing CTKB's Current Deferred Revenue over 5 years: stood at $13.0 million in 2022, then soared by 74.77% to $22.7 million in 2023, then advanced by 12.32% to $25.5 million in 2024, then rose by 11.82% to $28.5 million in 2025, then increased by 5.36% to $30.0 million in 2026.
- The last three Current Deferred Revenue figures came in at $30.0 million (Q1 2026), $28.5 million (Q4 2025), and $28.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.21 Mn |
| Mar 31, 2026 | 30.03 Mn |
| Dec 31, 2025 | 28.50 Mn |
| Sep 30, 2025 | 28.74 Mn |
| Jun 30, 2025 | 28.13 Mn |
| Mar 31, 2025 | 27.71 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Sep 30, 2024 | 25.37 Mn |
| Jun 30, 2024 | 23.97 Mn |
| Mar 31, 2024 | 23.01 Mn |
| Dec 31, 2023 | 22.70 Mn |
| Sep 30, 2023 | 23.05 Mn |
| Jun 30, 2023 | 29.64 Mn |
| Mar 31, 2023 | 16.51 Mn |
| Dec 31, 2022 | 12.99 Mn |
| Sep 30, 2022 | 12.09 Mn |
| Jun 30, 2022 | 15.92 Mn |
| Mar 31, 2022 | 10.04 Mn |
| Dec 31, 2021 | 7.08 Mn |
| Sep 30, 2021 | 5.89 Mn |